Glycemic Outcomes and Safety With Minimed 780G System in Children With Type 1 Diabetes Aged 2-6 Years

NCT04949022 · clinicaltrials.gov ↗

NA

Phase

UNKNOWN

Status

38

Enrollment

OTHER

Sponsor class

Conditions

Type 1 Diabetes

Interventions

DEVICE: Medronic 780G insulin pump

Sponsor

Helsinki University Central Hospital

Collaborators

[object Object]